Ran into this while researching breast cancer.
-------------------------------------------------------------------------
"J Nutr Health Aging. 1999;3(2):92-101. Related Articles, Links
Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction.
Kari FW, Dunn SE, French JE, Barrett JC.
Laboratory of Environmental Carcinogenesis and Mutagenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709, USA.
This paper focuses on the role of insulin-like growth factor-1 (IGF-1) and its associated regulatory apparatus as a key endocrine, autocrine, and paracrine signalling system involved in mediating the anti-carcinogenic activity of dietary restriction. Literature is reviewed showing that the inhibitory action of dietary restriction on carcinogenesis is global and pervasive--it is effective in several laboratory species, for a variety of tumor types, and for both spontaneous tumors and tumors caused by different types of tumor-inducing agents. Evidence is presented showing the IGF-1 pathway responds appropriately to nutritional interventions including diet restriction. Recent evidence points to an obligatory role for the IGF-1 receptor in the establishment and maintenance of the transformed phenotype and reveals that IGF-1 in concert with insulin-like binding protein 3 and p53 is involved in autocrine/paracrine growth signaling pathways as adaptive responses to environmental stimuli. Considered together these works show that the IGF-1 pathway is uniquely poised to influence cellular transformation leading to the malignant phenotype by modulating the balance of cellular proliferation and cell death (apoptosis) in precancerous and cancerous cells and by influencing metastasis of nascent tumors. We evaluated these hypotheses directly using animal models of mononuclear cell leukemia, bladder transitional cell carcinogenesis, and breast cancer. Our studies demonstrate that manipulation of IGF-1 level through dietary intervention influences tumor growth and metastasis. Upregulation of this pathway demonstrated that increased IGF-1 stimulates tumor proliferation, progression and metastasis. Conversely, downregulation of this pathway in vivo as a consequence of dietary restriction results in antitumorigenic activity. We found that the functional disruption of IGF-1R markedly influences breast cancer metastasis in nude mice by suppressing cellular adhesion, invasion, and metastasis of breast cancer cells to the lung, lymph nodes, and lymph vessels. Epidemiological observations and clinical oncology results support the involvement of IGF-1 in carcinogenesis and anticarcinogenesis. This leads to the hypothesis that factors such as IGF-1 which regulate body size and composition may be related to human cancer incidence or prognosis. Additional understanding of this pathway and its interactions with other signaling pathways will advance our ability to develop new interventions towards decreased cancer risk in humans.
Publication Types:
Review
Review, Tutorial
PMID: 10885804 [PubMed - indexed for MEDLINE] "
--------------------------------------------------------------------------
We know that caloric restriction has a number of favorable effects in terms of life span, cancer prevention, etc... This being due to multiple factors; the general trend of decreased metabolic and hormonal actions, general catabolism, decreased protein synthesis, and so on which accompanies a hypocaloric state. We also know that IGF-1 and related growth factors play powerful roles in many common carcinomas (such as many breast cancer lines).
My question, regarding the abstract, is why does a downregulation of IGF-1 [action] correlate with caloric restriction? It was my understanding that in the general diet model, GH output increases. Would this not be opposite of what is proposed? Am I misreading the study and/or attributing IGF-1 with GH incorrectly? If I'm not, then one explanation I can think of would be since we know that in a fed/hypercaloric state, a general upregulation of many metabolic and hormonal actions occurs; such as increased estrogen induced GH/IGF-1 elevation (systemicly--liver). Maybe such an increase is cumulatively greater than the hypocaloric induced GH increase? Does that make sense? I'm gonna dig through the 'related articles' link at PubMed and see if I can find the flaw in my thinking here.
Also just curious for any related general or specific thoughts on caloric restriction and its anti-cancer effects... is interesting to me.